Evidence map›Paper›PMID 42127131›Full record

ArticlePloS one2026

Unraveling dimethylformamide-induced neutrophilic differentiation in HL-60 cells: A proteomic and functional comparison with dimethyl sulfoxide.

Othman Eldalal, Yasser Tabana, Dinesh Babu, Newton H Tran, Steven Lockhart, Joshua Kranrod, John M Seubert, Lusine Tonoyan, Richard P Fahlman, Arno G Siraki

Abstract readComparative Study
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Othman EldalalFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0003-0114-9141
Yasser TabanaDepartment of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Dinesh BabuLi Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Newton H TranFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0009-0008-1446-6369
Steven LockhartFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0001-5882-756X
Joshua KranrodFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0001-8596-3153
John M SeubertFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.
Lusine TonoyanFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.
Richard P FahlmanDepartment of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Arno G SirakiFaculty of Pharmacy & Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The differentiation of HL-60 cells into neutrophil-like cells is widely used to study neutrophil functions, yet no comprehensive proteomic analysis has been conducted on dimethylformamide (DMF)-induced differentiation. This study provides the first detailed proteomic characterization of DMF-differentiated (df)-HL-60 cells, demonstrating its distinct molecular and functional profiles compared to the well-established dimethyl sulfoxide (DMSO)-df-HL-60 cell model. HL-60 cells were differentiated using 1.25% DMSO or 70 mM DMF for five days. Cell proliferation, granulocytic differentiation (CD11b expression), superoxide anion production, myeloperoxidase (MPO) protein expression and enzymatic activity, and neutrophil extracellular trap (NET) formation were evaluated. Proteomic profiling was performed using LC-MS/MS, followed by gene ontology and pathway enrichment analysis to identify key molecular changes associated with differentiation. DMF-df-HL-60 cells maintained higher proliferation rates than DMSO-df-HL-60 cells. Both agents successfully induced granulocytic differentiation, with DMSO producing greater CD11b expression. Functionally, both differentiation methods enhanced superoxide anion production, but DMF-df-HL-60 cells generated distinct superoxide radical spectra when evaluated with EPR spectroscopy. MPO protein expression and activity were significantly reduced in both differentiation models, indicating a transition to a mature neutrophil-like phenotype. Proteomic analysis revealed that neutrophil degranulation was the most significantly enriched pathway in DMF-df-HL-60 cells, alongside pathways involved in oxidant production and receptor tyrosine kinase signaling. Furthermore, S100 calcium-binding protein A9 (S100A9) abundance was significantly higher in DMF-df-HL-60 cells, suggesting a novel role of DMF in modulating neutrophil differentiation. DMF-df-HL-60 cells also showed activation of MAPK, Ras, and Rap1 signaling pathways, similar to the DMSO-df-HL-60 cell model, which is crucial for differentiation and immune responses. DMF-df-HL-60 cells generated more NETs than the DMSO-df-HL-60 cell model with phorbol myristate acetate. This study emphasizes the importance of selecting the appropriate differentiation model to accurately mimic neutrophil biology and highlights DMF's unique role in neutrophil differentiation, providing novel insights into differentiation-induced functional adaptations.

Indexed as

Cell DifferentiationDimethylformamideDimethyl SulfoxideNeutrophilsProteomicsCell ProliferationHL-60 CellsHumansPeroxidaseProteomeSignal TransductionSuperoxidesDimethylformamideDimethyl SulfoxidePeroxidaseProteomeSuperoxides

Identifiers

PMID42127131
PMCPMC13170858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.